MapLight Therapeutics, Inc. (MPLT) › Capital ExpendituresMapLight Therapeutics, Inc. (MPLT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2024: $770.0K2025: $473.0K$473.0K2024Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$473.0K-38.6%2024$770.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share